232 related articles for article (PubMed ID: 25762117)
1. Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
Ladeiras-Lopes R; Fontes-Carvalho R; Bettencourt N; Sampaio F; Gama V; Leite-Moreira A
Expert Opin Ther Targets; 2015 Jul; 19(7):869-77. PubMed ID: 25762117
[TBL] [Abstract][Full Text] [Related]
2. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
3. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
Paneni F; Costantino S; Cosentino F
G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
[TBL] [Abstract][Full Text] [Related]
4. Metformin in patients with chronic kidney disease: strengths and weaknesses.
Rocha A; Almeida M; Santos J; Carvalho A
J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism].
Lavrenko AV; Shlykova OA; Kutsenko LA; Mamontova TV; Kaĭdashev IP
Ter Arkh; 2012; 84(9):35-40. PubMed ID: 23091851
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
Ovalle F
Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
[TBL] [Abstract][Full Text] [Related]
7. Metformin: risk-benefit profile with a focus on cancer.
Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
[TBL] [Abstract][Full Text] [Related]
8. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
9. Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.
Nesti L; Natali A
Nutr Metab Cardiovasc Dis; 2017 Aug; 27(8):657-669. PubMed ID: 28709719
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effectiveness of metformin and ramipril combination in complex therapy of patients with metabolic syndrome].
Savchenko LH; Kaĭdasheva EI; Kutsenko LO; Kutsenko NL; Hordyns'ka IL; Mamontova TV; Markina TM; Kaĭdashev IP
Lik Sprava; 2013; (1):109-17. PubMed ID: 23951921
[TBL] [Abstract][Full Text] [Related]
11. The cardioprotective effects of metformin.
El Messaoudi S; Rongen GA; de Boer RA; Riksen NP
Curr Opin Lipidol; 2011 Dec; 22(6):445-53. PubMed ID: 21897229
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
Palomba S; Falbo A; Zullo F; Orio F
Endocr Rev; 2009 Feb; 30(1):1-50. PubMed ID: 19056992
[TBL] [Abstract][Full Text] [Related]
13. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy in diabetes: the role of cardioprotection.
El Messaoudi S; Rongen GA; Riksen NP
Curr Atheroscler Rep; 2013 Apr; 15(4):314. PubMed ID: 23423523
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and the metabolic syndrome--when is it best to intervene to prevent?
Haffner S
Atheroscler Suppl; 2006 Apr; 7(1):3-10. PubMed ID: 16504598
[TBL] [Abstract][Full Text] [Related]
16. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
17. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
Esser N; Paquot N; Scheen AJ
Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
[TBL] [Abstract][Full Text] [Related]
19. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
Calvert JW; Gundewar S; Jha S; Greer JJ; Bestermann WH; Tian R; Lefer DJ
Diabetes; 2008 Mar; 57(3):696-705. PubMed ID: 18083782
[TBL] [Abstract][Full Text] [Related]
20. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
